The product information itself tells prescribers: In case of significant gastrointestinal symptoms, consider delaying dose escalation or lowering to the previous dose until symptoms have improved. 1 That is a prescribers decision and not something to do on your own
is grateful to Thierry Sulpice and Nourdine Faresse (Physiogenex S.A.S.) for insightful discussions
BPC-157 typically isnt part of standard drug tests, but athletes should verify with relevant organizations to ensure compliance with regulations
[DOI] [PubMed] [Google Scholar] Jophlin LL, Singal AK, Bataller R, Wong RJ, Sauer BG, Terrault NA, et al
If you want a deeper look at the compound itself, Cymbiotikas article on liposomal glutathione absorption is a helpful follow-up